Literature DB >> 20445191

Eculizumab and renal transplantation in a patient with CAPS.

Bonnie E Lonze, Andrew L Singer, Robert A Montgomery.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20445191     DOI: 10.1056/NEJMc0910965

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  33 in total

Review 1.  The rheumatology/hematology interface: CAPS and MAS diagnosis and management.

Authors:  John M Gansner; Nancy Berliner
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

Review 2.  Renal involvement in antiphospholipid syndrome.

Authors:  Francisco Vileimar Andrade de Azevedo; Diego Germano Maia; Jozelio Freire de Carvalho; Carlos Ewerton Maia Rodrigues
Journal:  Rheumatol Int       Date:  2018-05-05       Impact factor: 2.631

Review 3.  Immunosuppressive drug therapy.

Authors:  Choli Hartono; Thangamani Muthukumar; Manikkam Suthanthiran
Journal:  Cold Spring Harb Perspect Med       Date:  2013-09-01       Impact factor: 6.915

4.  Top 10 clinical research developments in antiphospholipid syndrome.

Authors:  Medha Barbhaiya; Doruk Erkan
Journal:  Curr Rheumatol Rep       Date:  2013-10       Impact factor: 4.592

5.  Off-label use of the expensive orphan drug eculizumab in France 2009-2013 and the impact of literature: focus on the transplantation field.

Authors:  Johann Castañeda-Sanabria; David Hajage; Melisande Le Jouan; Anne Perozziello; Florence Tubach
Journal:  Eur J Clin Pharmacol       Date:  2016-02-26       Impact factor: 2.953

Review 6.  Antibodies Against Complement Components: Relevance for the Antiphospholipid Syndrome-Biomarkers of the Disease and Biopharmaceuticals.

Authors:  Mirjana Bećarević
Journal:  Curr Rheumatol Rep       Date:  2017-07       Impact factor: 4.592

Review 7.  Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies.

Authors:  Julien Zuber; Fadi Fakhouri; Lubka T Roumenina; Chantal Loirat; Véronique Frémeaux-Bacchi
Journal:  Nat Rev Nephrol       Date:  2012-10-02       Impact factor: 28.314

8.  Anti-complement component C5 mAb synergizes with CTLA4Ig to inhibit alloreactive T cells and prolong cardiac allograft survival in mice.

Authors:  H Raedler; M B Vieyra; S Leisman; P Lakhani; W Kwan; M Yang; K Johnson; S J Faas; P Tamburini; P S Heeger
Journal:  Am J Transplant       Date:  2011-06-10       Impact factor: 8.086

9.  Antiphospholipid syndrome presenting with acute digital ischaemia, avascular necrosis of the femoral head and superior mesenteric artery thrombus.

Authors:  Christopher Robert Crome; Sriram Rajagopalan; Ganesh Kuhan; Nicholas Fluck
Journal:  BMJ Case Rep       Date:  2012-11-20

Review 10.  Use of eculizumab in a systemic lupus erythemathosus patient presenting thrombotic microangiopathy and heterozygous deletion in CFHR1-CFHR3. A case report and systematic review.

Authors:  Maria Izabel de Holanda; Luis Cristóvão Pôrto; Teresa Wagner; Luis Fernando Christiani; Lilian M P Palma
Journal:  Clin Rheumatol       Date:  2017-09-13       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.